GENERAL ATLANTIC, L.P. — 13F Holdings

2026 Q2  ·  15 Positions

2026 Q2 Portfolio Activity

In 2026 Q2, GENERAL ATLANTIC, L.P. maintained a portfolio of 15 distinct positions. The most significant new addition was LIFTOFF MOBILE, now representing 20.92% of the total fund value. They heavily accumulated shares in ALKAMI, increasing the position by 26.4%. Conversely, GENERAL ATLANTIC, L.P. completely exited their position in EUROPEAN WAX CENTER.
Position History hover any row below to update
Loading…
GENERAL ATLANTIC, L.P. New York, NY Global Growth Equity / Private Equity AUM $2,907M
PCA Score Concentration Risk
Risk ENB
Total Positions
15
Quarter
2026 Q2
Top Holding
N/A (20.9%)
Top 10 Concentration
99.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-15 of 15

GENERAL ATLANTIC, L.P. Full Holdings List — 2026 Q2

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
N/A
LIFTOFF MOBILE
Unknown 20.92% #1
Prev: #—
9.5
25,315,646
NEW
25,315,646 $608,081,817 13F Filing 2026-06-30 2026-08-14
DLO
DLOCAL
Technology 20.86% 28.17% #2 1
Prev: #1
6.5
no change no change
P
S
46,656,695 $606,303,752 2021 Q2 13F Filing 2026-06-30 2026-08-14
CHYM
CHIME
Technology 14.98% 18.53% #3 1
Prev: #2
6.0
no change no change
P
S
21,259,683 $435,398,308 2025 Q2 13F Filing 2026-06-30 2026-08-14
ALKT
ALKAMI
Technology 12.08% 11.19% #4
Prev: #4
7.0
4,041,543 26.4%
P
S
19,379,038 $351,148,169 2021 Q2 13F Filing 2026-06-30 2026-08-14
XP
XP, INC
Financial Services 11.50% 18.23% #5 2
Prev: #3
5.5
no change no change
P
S
20,566,133 $334,405,323 2019 Q4 13F Filing 2026-06-30 2026-08-14
PHVS
PHARVARIS
Healthcare 7.79% 10.56% #6 1
Prev: #5
3.6
-1,480,495 -18.4%
P
S
6,550,757 $226,525,177 2021 Q1 13F Filing 2026-06-30 2026-08-14
N/A
SEAPORT THERAPE...
Unknown 4.56% #7
Prev: #—
5.3
6,101,582
NEW
6,101,582 $132,526,361 13F Filing 2026-06-30 2026-08-14
NRIX
NURIX THERAPEUT...
Healthcare 2.53% 2.96% #8
Prev: #8
1.0
-1,069,680 -26.1%
P
S
3,032,185 $73,560,808 2025 Q4 13F Filing 2026-06-30 2026-08-14
RVMD
REVOLUTION MEDI...
Healthcare 2.31% 3.20% #9 2
Prev: #7
0.9
-350,000 -49.4%
P
S
357,791 $67,007,098 2025 Q3 13F Filing 2026-06-30 2026-08-14
N/A
PARABILIS MEDIC...
Unknown 1.45% #10
Prev: #—
4.1
1,538,461
NEW
1,538,461 $42,107,678 13F Filing 2026-06-30 2026-08-14
RSKD
RISKIFIED
Technology 0.92% 0.97% #11 1
Prev: #10
1.4
no change no change
P
S
5,324,998 $26,837,990 2021 Q3 13F Filing 2026-06-30 2026-08-14
GROV
GROVE COLLABORA...
Consumer Defensive 0.11% 0.15% #12 1
Prev: #11
1.0
no change no change
P
S
2,474,859 $3,093,574 2023 Q2 13F Filing 2026-06-30 2026-08-14
BULL
WEBULL
Technology 0.00% 0.01%
Sold All 😨
(Was: #12)
0.0
-50,816 -100.0%
CLOSED
$— 2025 Q2 13F Filing 2026-06-30 2026-08-14
CNTA
CENTESSA PHARMA...
Healthcare 0.00% 2.50%
Sold All 😨
(Was: #9)
0.0
-1,354,830 -100.0%
CLOSED
$— 2021 Q2 13F Filing 2026-06-30 2026-08-14
EWCZ
EUROPEAN WAX CE...
Consumer Defensive 0.00% 3.53%
Sold All 😨
(Was: #6)
0.0
-13,110,492 -100.0%
CLOSED
$— 2021 Q3 13F Filing 2026-06-30 2026-08-14
Showing 1-15 of 15 holdings

Unlock Full GENERAL ATLANTIC, L.P. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →